Clinical Trial

Effect of Indoor Air Quality Improvement on Health in Patients With Interstitial Lung Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Air pollution threatens the respiratory health of patients with interstitial lung disease (ILD). High-efficiency air purifiers, featuring easy operation and excellent particulate matter removal efficiency, have been shown in previous studies to potentially delay lung function deterioration and reduce acute exacerbation risk in respiratory disease patients. This randomized crossover study employs air purifiers to filter indoor gaseous pollutants, allergens, and other contaminants, aiming to alleviate respiratory irritation, improve daily life comfort, and enhance overall health status in ILD patients.
Trial Details
NCT Number NCT07344987
Lead Sponsor Peking Union Medical College
Conditions ILD
Enrollment 100 participants
Start Date 2026-03
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-15